Optime Care, Specialty Pharmacy Patient Management Organization Announces Enhanced Partnership with Rigel Pharmaceuticals, Inc. for Rezlidhia™ Patients
Optime Care Recognizes Role of Caregivers for Individuals with Rare Disease, Chronic, Complex Conditions
RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter, a globally leading contract development and manufacturing organization (CDMO), has in place a comprehensive sustainability strategy that has made it a pioneer in this energy-intensive industry. The family-owned company is undertaking numerous initiatives aimed at making sustainability manifest in all facets for employees and acts as a motivator in encouraging them to participate. For the second time in a row, Vetter participated in a full week of life activities in the recent Sustainability Days of Baden-Wuerttemberg’s Sustainability Network. “To just speak about the topic of sustainability does not give it the credit it is due,” says Vetter Managing Director Thomas Otto. “That is why we are part of a proactive network of other companies. We need a strong community for sustainable development and we work hard to include all employees in the process.” Within this context, the CDMO has launched numerous sustainability activities that include various participatory events and lectures. This includes an information booth that traveled among company sites. Its aim is to sensitize all employees to the issue of sustainability and offer them easy-to-implement, hands-on suggestions that can enable greater sustainability in their professional and private lives.
EARTH CITY, Mo.--(BUSINESS WIRE)--Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, announces its support of the inaugural Gene Therapy and Specialty Pharmacy Awareness month, September 2022. The observance is included in the annual Calendar of Health Observances & Recognition Days, published by The Society for Health Care Strategy & Market Development (SHSMD) of the American Hospital Association and was founded by its parent company, AscellaHealth Family of Companies.
BERWYN, Pa. & EARTH CITY, Mo.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy services organization and Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, today announce their collaboration with the National Association of Specialty Pharmacy (NASP) to release a four-part podcast series that assists healthcare providers with insights into the patient journey and overcoming challenges for individuals with rare diseases and complex, chronic conditions. The final podcast episode will be recorded LIVE at the NASP 2022 Annual Meeting & Expo - Gaylord Palms Resort & Convention Center, Orlando, Florida, Sept. 19-22, 2022.
EARTH CITY, Mo.--(BUSINESS WIRE)--Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, announces continued staff expansion at its St. Louis operation to meet client demand. The company now employs 66 people, an increase of 200% from 2015 when operations began.
EARTH CITY, Mo.--(BUSINESS WIRE)--Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, announces the launch of Copay AdvisorSM, a first-in-class, innovative copay assistance program to proactively address challenges and unmet needs of its drug manufacturer partners. Utilizing proprietary block-chain technology as its backbone, Copay AdvisorSM minimizes potentially negative exposure with co-pay and maximizer programs for pharmaceutical manufacturers.
EARTH CITY, Mo.--(BUSINESS WIRE)--Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to recognize Feb. 28 as Rare Disease Day and help raise awareness of the 7,000+ rare diseases that impact over 300 million people globally. Optime Care’s patient-first approach supports family caregivers and patients through counseling, guidance and education based upon patient and caregiver needs, optimizing the therapeutic value of a specialty drug by ensuring prescription accuracy, compliance, adherence to treatment and side effects management.
EARTH CITY, Mo.--(BUSINESS WIRE)--Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to announce that in collaboration with the National Association of Specialty Pharmacy (NASP), providers of networking, continuing education, pharmacist certifications and public policy advocacy for specialty pharmacy, Optime Care will develop and distribute a podcast with the Pharmacy Podcast Network. The series focuses on the patient journey mapping experience across the Specialty Pharmacy (SP) and healthcare spectrum, addressing internal and external factors that impact SP channel and services to the patient. This will include discussion moderated, by Michael Baldzicki, executive vice president of Growth & Strategy at AscellaHealth, about product criteria, price, site of care, clinical management, health plan design, complexity of administration, specialty handling, and overall patient compliance and engagement.
BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global specialty pharmacy and healthcare solutions company, today announces its strategic alliance with Optime Care to further enhance its ability to become a leader in Specialty Pharmacy (SP) services and establish a strong trajectory for growth. AscellaHealth’s comprehensive suite of services provides solutions for all industry segments, with support for payers to achieve cost-effective access and Life Sciences services including pre-commercialization and outsourced market access capabilities, wholesale, distribution and third-party logistics services, SP limited distribution drug (LLD) fulfillment with national reach and high-touch patient capabilities, and patient support/Hub services for Life Sciences.